Latest Merck News & Updates

See the latest news and media coverage for Merck. We track all announcements, press releases, and industry mentions in real time, all in one place.

Merck

Research-intensive biopharmaceutical company

merck.com

Headquarters: Rahway, United States
Company type: Public company
Number of employees: 40,000+

Last updated Today

Latest news about Merck

In short: Merck secured several FDA approvals for vaccines and cancer therapies, while expanding its oncology and animal health portfolios through strategic deals.

Company announcements

Yesterday Merck

Merck's tulisokibart met endpoints in Phase 3 UC study

The anti-TL1A antibody showed clinical remission at 12 weeks, with no safety concerns identified.

June 18 Merck

Merck's CAPVAXIVE gets FDA approval for at-risk children

The vaccine is indicated for children aged 2-17 with increased pneumococcal disease risk, adding serotype coverage.

June 12 Merck

Merck announces FDA approval of KEYTRUDA combinations

Approvals add WELIREG combinations for adjuvant treatment of intermediate‑high or high‑risk ccRCC after nephrectomy. Based on Phase 3 LITESPARK‑022 showing 28% reduced risk of recurrence, metastasis or death.

June 11 Merck

Merck Animal Health to acquire TARGAN

The acquisition includes TARGAN's biodevice technology for poultry performance improvement.

Media coverage

Today Yahoo Finance

The $50B Plan Merck Stock Was Broadcasting

Before its fifty percent surge, the drug giant was repeatedly telling a story about its future that the market seemed to be ignoring.

Yesterday Yahoo Finance

Merck (MRK) Wins FDA Expansions, Posts HIV Data, And Ends Lung Cancer Trial

Merck (NYSE:MRK) received FDA approval for expanded use of KEYTRUDA and KEYTRUDA QLEX with WELIREG as adjuvant treatment in certain renal cell carcinoma patients. The...

Yesterday Reuters

Merck s bowel disease drug meets main goal in late-stage trial

, opens new tab said on Monday its experimental drug met the main goal and key secondary goals in a ...

June 21 Seeking Alpha

Healthcare headlines highlight Merck, Moderna, and Biogen

XLV falls as Moderna surges; CMS drug-price rule pressures Merck and J&J; Lilly and Biogen announce deals.

Never miss news about Merck

Track Merck and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Merck competitors & trending companies

Browse news for competitors to Merck and other trending companies.